"The company has received World Health Organization (WHO) prequalification for the product Sulfadoxine," says the Mumbai-based pharma company in its filing to the exchange.
first published: Dec 17, 2015 10:36 am
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty bulls aim to break 25,250 after strong TCS Q2? | Opening Bell
TCS Q2 Earnings Live: Margin, Revenue Beat Street Estimates
Live: Nifty reclaims 25,100 ahead of TCS Q2 results; pharma, metals shine | Closing Bell
Canara Robeco AMC's Rs 1326 Cr IPO Kicks Off | Management Shares Growth Plans| IPO Watch Live
You are already a Moneycontrol Pro user.